
Intelgenx Technologies Corp Investor Relations Material
Latest events

Q4 2023
Intelgenx Technologies Corp
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intelgenx Technologies Corp
Access all reports
Intelgenx Technologies Corp. is a pharmaceutical company focused on drug delivery solutions through its proprietary oral thin film technologies. Its primary product offering includes innovative oral films that provide immediate or controlled drug release, easing administration and improving patient compliance. The company also engages in the development of transdermal patches. Its film delivery platforms are applied across various therapeutic areas, with applications in human and animal health. The company is headquartered in Saint-Laurent, Quebec, Canada, and its shares are listed on the TSX.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
IGX
Country
🇨🇦 Canada